๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 51 Guangzhou 16 Changchun 10 Shanghai 9 Fuzhou 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Capital Medical University10 Xuanwu Hospital, Beijing6 Beijing Tiantan Hospital6 Beijing Anzhen Hospital4 Beijing Shijitan Hospital, Capital Medical University2
Site location
Beijing51 Guangzhou16 Changchun10 Shanghai9 Fuzhou8
All 121 locations
Target enrolment
to

Trials with a site in Beijing

51 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL-2)
NCT07800572Acute Ischemic Stroke
DrugAnisodine Hydrobromide
Capital Medical University
Phase 2
204
Anyang, Beijing, Huzhou, Jiuquan, Lishui, Shangqiu, Suzhou, Taizhou
2026-09-06
Not yet open
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic Stroke
NCT07754825Acute Ischemic Stroke
DrugLT3001 Drug
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
300
Beijing
2026-09-01
Not yet open
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients
NCT07739160Acute Ischemic Stroke
DrugHRS-4029
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 2
340
Beijing
2026-08-15
Not yet open
Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events
NCT07748039Acute Ischemic Stroke, Large Vessel Occlusion, Anterior Circulation Brain Infarction
DrugRhTNK-tPA
Yongjun Wang
Phase 3
1,440
Beijing, Wuhan, Xiangtan, Rizhao, Ya'an
2026-08-01
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation Monitoring
NCT07747701Acute Ischemic Stroke, Cerebral Autoregulation
Beijing Shijitan Hospital, Capital Medical University
Not applicable
227
Beijing, Dalian, Heilongjiang, Shandong
2026-07-31
Recruiting
Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy
NCT07049692Acute Ischemic Stroke
Beijing Chao Yang Hospital
Not applicable
424
Beijing
2026-07-22
Recruiting
Early Identification and Diagnosis of BAD-related Stroke
NCT07693816Branch Atheromatous Disease, Acute Ischemic Stroke, Cerebral Infarction
Peking Union Medical College Hospital
Observational
1,602
Beijing
2026-07-15
Not yet open
A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke
NCT07628933Acute Ischemic Stroke, AIS
BOE Technology Group Co., Ltd.
Phase 1
35
Beijing
2026-06-30
Recruiting
Sivelestat Sodium as an Adjunct to Endovascular Thrombectomy for Acute Anterior Circulation Large-Vessel Occlusion
NCT07552610Acute Ischemic Stroke, Large Vessel Occlusion, Thrombectomy, Neutrophil Extracellular Trap Formation
DrugSivelestat sodium
Xuanwu Hospital, Beijing
Not applicable
868
Weifang, Beijing
2026-06-22
Not yet open
Direct Angio Suite Acute Stroke Intervention With CT/DSA Hybrid Emergency Stroke Unit
NCT07670065Acute Ischemic Stroke, Large Vessel Occlusion
Beijing Tiantan Hospital
Phase 3
232
Beijing
2026-06-08
Recruiting
Human Placenta-derived 3D Mesenchymal Stem Cells(Guojianqingke)
NCT07635758Acute Ischemic Stroke
Chinese PLA General Hospital
Phase 1/2
24
Beijing
2026-06-01
Not yet open
Efficacy and Safety of Bailout Intracranial Angioplasty or Stenting After Thrombectomy for Acute Intracranial Atherosclerotic Large Vessel Occlusion (ANGEL-REBOOT 2)
NCT07618052Intracranial Atherosclerotic Stenosis-Related Large Vessel Occlusion, Acute Ischemic Stroke, Bailout Angioplasty or Stenting
Feng Gao
Not applicable
420
Beijing
2026-06-01
Recruiting
A Study of TAK-755 in Adults With Acute Ischemic Stroke
NCT07392450Acute Ischemic Stroke
DrugTAK-755
Takeda
Phase 2
222
Beijing, Nanyang, Xuzhou, Jinan, Liaocheng, Linyi, Datong, Linfen
2026-05-17
Recruiting
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
NCT07519044Stroke, Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Phase 4
868
Beijing, Shandong
2026-05-14
Active, closed
Anisodine Hydrobromide for Patients With Acute Ischemic Stroke Undergoing Endovascular Therapy (HEAL)
NCT07513233Acute Ischemic Stroke
DrugAnisodine Hydrobromide
Capital Medical University
Phase 1
92
Zhangzhou, Jiuquan, Yulin, Shangqiu, Xuzhou, Beijing, Zibo, Huzhou
2026-04-28
Recruiting
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke Based on Cerebral Autoregulation
NCT07556068Acute Ischemic Stroke, Cerebral Autoregulation
Beijing Shijitan Hospital, Capital Medical University
Observational
129
Beijing, Harbin, Dalian, Weifang
2026-04-20
Not yet open
The Feasibility and Safety of RK-4 Injection Bypassing Blood-brain Barrier in the Treatment of Acute Large Hemispheric Infarction Using Intracalvariosseous Injection Device
NCT07514949Stroke, Acute Ischemic Stroke, Blood-Brain Barrier
yilong Wang
Not applicable
6
Beijing
2026-04-15
Not yet open
Emergency Stroke Unit With NeuAngio-CT (ESU-ACT)
NCT07456228Acute Ischemic Stroke
Beijing Tiantan Hospital
Observational
500
Beijing
2026-03
Recruiting
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302Acute Ischemic Stroke
DrugTenecteplase
Boehringer Ingelheim
Phase 3
1,325
Anyang, Baoji, Baotou, Beijing, Cangzhou, Changchun, Changsha, Chengdu
2026-02-17
Recruiting
Telemedicine-supported Management for Acute Ischemic Stroke
NCT07302971Acute Ischemic Stroke
Capital Medical University
Not applicable
2,400
Beijing
2026-02-02
Not yet open
The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke
NCT07269288Acute Ischemic Stroke
Peking University Aerospace Center Hospital
Observational
1,500
Beijing
2026-01-25
Recruiting
Tenecteplase Before Interhospital Transfer in Acute Basilar Artery Occlusion at 4.5 to 24 Hours
NCT07203625Acute Ischemic Stroke, Basilar Artery Occlusion
DrugsTenecteplase thrombolysis·RhTNK-tPA
Xuanwu Hospital, Beijing
Phase 4
316
Beijing
2026-01-20
Not yet open
Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion
NCT07335107Acute Ischemic Stroke
DrugTirofiban
Beijing Tiantan Hospital
Phase 3
564
Beijing
2026-01-12
Recruiting
Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 Hours
NCT07253181Acute Ischemic Stroke, Large Vessel Occlusion, Transportation of Patients
DrugsTenecteplase (TNK)·Maximum
Xuanwu Hospital, Beijing
Phase 3
572
Beijing, Weifang
2026-01-06
Recruiting
A Study of B2065 in Patients With Acute Ischemic Stroke
NCT07371624Acute Ischemic Stroke
Tasly Pharmaceutical Group Co., Ltd
Phase 1/2
54
Beijing
2025-12-31
Active, closed
Efficacy and Safety of Home-based Structured Physical Exercise in Patients With Acute Ischemic Stroke
NCT07271082Acute Ischemic Stroke
Capital Medical University
Not applicable
208
Fuyang, Suzhou, Beijing, Zhoukou, Shihezi
2025-12-18
Recruiting
Albumin for Patients With Acute Large Vessel Occlusive Stroke Undergoing Endovascular Therapy -2
NCT07263308Acute Ischemic Stroke
DrugAlbumin
Capital Medical University
Phase 3
1,192
Anqing, Bozhou, Fuyang, Maโ€™anshan, Suzhou, Wuhu, Beijing, Fuzhou
2025-12-18
Recruiting
Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke
NCT07279493Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.
Phase 2
300
Beijing, Shenzhen, Cangzhou, Hengshui, Daqing, Anyang, Nanyang, Xuzhou
2025-11-22
Recruiting
Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke
NCT07290751Acute Ischemic Stroke
DrugTirofiban
Beijing Anzhen Hospital
Phase 4
976
Beijing
2025-11-11
Recruiting
Urokinase for Thrombolysis in Acute Ischemic Stroke
NCT07047326Acute Ischemic Stroke
Capital Medical University
Not applicable
24
Beijing, Handan
2025-10-01
Recruiting
A Clinical Trial of MT200605 for the Treatment of Acute Ischemic Stroke
NCT07205328Acute Ischemic Stroke
Shaanxi Micot Pharmaceutical Technology Co., Ltd.
Phase 2
360
Beijing
2025-10
Not yet open
RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction
NCT07166380Transcranial Bone Marrow Injection, RK-4, Acute Large Hemispheric Infarction, Acute Ischemic Stroke
Neurodawn Pharmaceutical Co., Ltd.
Phase 1/2
18
Beijing
2025-09-20
Recruiting
Endovascular Therapy Combined With Tirofiban for Intracranial Atherosclerotic Acute Ischemic Stroke
NCT07026318Acute Ischemic Stroke
DrugTirofiban
Beijing Anzhen Hospital
Not applicable
716
Beijing
2025-08-15
Active, closed
Efficacy of Rescue Stenting/Angioplasty After Failed Thrombectomy for Acute Large Intracranial Vascular Occlusion
NCT07026344Acute Ischemic Stroke
Beijing Anzhen Hospital
Not applicable
312
Beijing
2025-07-12
Recruiting
Effect of Balloon Angioplasty vs Stenting Following Residual Stenosis After Endovascular Treatment of Intracranial Atherosclerotic Acute Ischemic Stroke
NCT07026331Acute Ischemic Stroke, Intracranial Atherosclerosis ICAS
Beijing Anzhen Hospital
Not applicable
486
Beijing
2025-07-03
Recruiting
Qingre Huatan Formula for the Prevention of Early Neurological Deterioration in Acute Ischemic Stroke
NCT06857487Acute Ischemic Stroke
Dongzhimen Hospital, Beijing
Phase 1/2
72
Beijing
2025-06-13
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
NCT06990867Acute Ischemic Stroke
Corxel Pharmaceuticals
Phase 2/3
740
Baotou, Beijing, Changchun, Guangzhou, Harbin, Kaili, Linfen, Nanyang
2025-05-15
Recruiting
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489Large Vessel Occlusion, Acute Ischemic Stroke
First Affiliated Hospital of Wannan Medical College
Observational
500
Wuhu, Baotou, Jinan, Henan, Beijing
2025-04-27
Recruiting
Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke
NCT06943885Acute Ischemic Stroke
Beijing Emergency Medical Center
Not applicable
952
Beijing
2025-04-25
By invitation
Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke Patients Receiving Reperfusion Treatment
NCT06848894Acute Ischemic Stroke
Beijing Tiantan Hospital
Not applicable
1,204
Beijing
2025-04-21
Not yet open
A Single Ascending Dose of HRS-4029 in Healthy Subjects
NCT06905314Acute Ischemic Stroke
DrugHRS-4029
Beijing Suncadia Pharmaceuticals Co., Ltd
Phase 1
55
Beijing
2025-04
Recruiting
Aleeto in Acute ISchemic Stroke๏ผšA RandomISed Controlled Clinical Trial
NCT06759753Acute Ischemic Stroke
Beijing Tiantan Hospital
Phase 2
192
Beijing
2025-03-21
Not yet open
Intra-arterial Hypothermic Magnesium Sulfate Infusion in Combination with Endovascular Thrombectomy in Acute Ischemic Stroke
NCT06760195Acute Ischemic Stroke
Capital Medical University
Phase EARLY_PHASE1
6
Beijing
2025-01-10
Recruiting
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
NCT06548971Acute Ischemic Stroke, Cerebral Infarction
DrugAspirin
Capital Medical University
Phase 3
1,184
Bengbu, Suzhou, Beijing, Haidian, Pinggu, Tongzhou, Fuzhou, Xiamen
2024-11-07
Recruiting
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated With Mechanical Thrombectomy๏ผˆRECAST-MT๏ผ‰
NCT06559241Acute Ischemic Stroke, Anterior Circulation Brain Infarction
Capital Medical University
Phase 3
2,105
Suzhou, Taihe Chengguanzhen, Tongling, Beijing, Fuzhou, Zhangzhou, Shenzhen, Nanning
2024-09-23
Recruiting
Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window
NCT06560203Acute Ischemic Stroke, Basilar Artery Occlusion
Capital Medical University
Not applicable
309
Beijing
2024-09-10
Recruiting
Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET)
NCT04916197Acute Ischemic Stroke
Beijing Chao Yang Hospital
Phase 4
368
Beijing
2024-03-01
Recruiting
Prognostic Prediction Model of Patients With AcUte Stroke undeRgoing EndOvascular TheRApy (AURORA)
NCT06009315Acute Ischemic Stroke
Beijing Tiantan Hospital
Observational
949
Beijing
2024-02-23
Recruiting
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Observational
50,000
Beijing
2023-04-25
Recruiting
Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke
NCT05686642Acute Ischemic Stroke
DrugLT3001 Drug
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 2
300
Beijing, Guangzhou, Luoyang, Hengshui, Daqing, Wuhan, Baotou, Huai'an
2023-04-06
Recruiting
XuanwuH Acute Ischemic Stroke Registry
NCT05208203Acute Ischemic Stroke
Xuanwu Hospital, Beijing
Observational
500
Beijing
2021-05-01
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

34 of the 51 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 13 have not yet opened recruitment, 3 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 51 studies
PhaseStudiesRecruitingShare
Not applicable14927.5%
Observational8615.7%
Phase 28615.7%
Phase 38515.7%
Phase 1/2437.8%
Phase 4447.8%
Phase 1305.9%
Phase 2/3112%
Phase EARLY_PHASE1102%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Capital Medical University107
Beijing Tiantan Hospital62
Xuanwu Hospital, Beijing66
Beijing Anzhen Hospital43
Beijing Chao Yang Hospital22
Beijing Shijitan Hospital, Capital Medical University22
Beijing Suncadia Pharmaceuticals Co., Ltd20
Shanghai Pharmaceuticals Holding Co., Ltd21
Beijing Emergency Medical Center11
BOE Technology Group Co., Ltd.10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.